Catalyst OrthoScience Features Innovative Products, Surgical Leaders And Archer™ 3D Targeting Imaging Software At AAOSCatalyst OrthoScience Features Innovative Products, Surgical Leaders And Archer™ 3D Targeting Imaging Software At AAOSCatalyst OrthoScience Features Innovative Products, Surgical Leaders And Archer™ 3D Targeting Imaging Software At AAOSCatalyst OrthoScience Features Innovative Products, Surgical Leaders And Archer™ 3D Targeting Imaging Software At AAOS
  • Home
  • Patients
    • Archer™ CSR Total Shoulder System
    • Archer™ R1 Reverse Shoulder System
    • Find A Surgeon
    • Patient Testimonials
  • Health Care Professionals
    • Archer™ CSR Total Shoulder System
    • Archer™ R1 Reverse Shoulder System
    • Archer™ 3D Targeting Software
    • HCP Testimonials & Case Studies
    • Technical Briefs
    • Catalyst in the Journals
  • News & Events
    • Events
    • News
    • Technical Briefs
    • Catalyst in the Journals
  • About Us
    • Executive Leadership
    • Board of Directors
    • Careers at Catalyst
  • Contact Us
Catalyst OrthoScience Introduces Archer™ 3D Targeting Imaging Software For Preoperative Planning
August 24, 2021
Catalyst Orthoscience Announces $12.3 Million Oversubscribed Financing round to Fuel Company Momentum in Shoulder Arthroplasty
October 6, 2021

Catalyst OrthoScience Features Innovative Products, Surgical Leaders And Archer™ 3D Targeting Imaging Software At AAOS

August 31, 2021

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.

View Press Release, August. 31, 2021

Catalyst OrthoScience Features Innovative Products, Surgical Leaders And Archer™ 3D Targeting Imaging Software At AAOS

Visit Booth #3452 for presentations from surgeons, demos of the Archer™ CSR Total Shoulder System and Archer™ R1 Reverse Shoulder System, and a preview of Archer™ 3D Targeting

NAPLES, Fla., August 31, 2021 – Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, will be at the American Academy of Orthopedic Surgeons (AAOS) 2021 Annual Meeting, September 1-3, 2021, in San Diego. At Booth #3452, Catalyst will host topical presentations by surgical opinion leaders and provide demonstrations of its innovative Archer™ CSR Total Shoulder System and Archer™ R1 Reverse Shoulder System. The company also will preview its recently announced Archer™ 3D Targeting, new imaging software that supports preoperative planning for shoulder arthroplasty.

The Catalyst Clinical Series at AAOS includes:

  • Improved Range-of-Motion Reported Using Stemless, Ellipsoid TSA System | Wednesday, Sept. 1, 1:00 - 1:30 pm; Matthew Budge, MD, Kaiser Permanente NW, Salem, OR
  • Why Change When What You're Using Works? When To Adopt New Technology | Thursday, Sept. 2, 1:00 - 1:30 pm; Zachary R. Leitze, MD, Intermountain Medical Group, St. George, UT
  • Surgical Pearls For The Archer CSR Total Shoulder System – Leveraging Five Years of Experience | Thursday, Sept. 2, 3:00 - 3:30 pm; Steven Goldberg, MD, Physicians Regional Medical Group, Naples, FL
  • Anatomic vs. rTSA – How Do You Decide? | Friday, Sept. 3, 10:15 - 10:45 am; Hafiz Kassam, MD, FRCSC, Sutter Health North Medical Group, Yuba City, CA

“AAOS brings together the sharpest minds in the field, and it’s the perfect opportunity to discuss how we can move forward together,” said Brian K. Hutchison, chairman and CEO of Catalyst. “We’re excited to share our latest innovations, including the Archer R1 system and Archer 3D Targeting, with orthopedic surgeons across the nation.”

Catalyst arrives at AAOS at a time of significant momentum for the company. In March, the company received FDA 510(k) clearance for the Archer R1 system and kicked off a limited user release in Q2 2021, sharing updates from the first surgeries in May. A commercial launch is planned for later this year. Catalyst also recently announced the introduction of Archer 3D Targeting imaging software to its offerings. With its Archer suite of shoulder systems, Catalyst supports the two fastest-growing segments of the shoulder arthroplasty market – stemless anatomic and reverse TSA – as well as preoperative planning.

  • Archer CSR Total Shoulder System is an anatomic stemless total shoulder arthroplasty solution that combines innovative components and unique instrumentation to bring about a precise, accurate restoration of the shoulder. It features a stemless, ellipsoid humeral component that is engineered to accurately replace the elliptical shape of the patient’s native non-spherical ​humeral head.
  • Archer R1 Reverse Shoulder System is a single-tray arthroplasty system that was engineered to combine the most beneficial and evidence-based attributes of reverse shoulder arthroplasty design. The system offers surgeon-targeted implant positioning, a streamlined and versatile system, and bone sparing implants.
  • Archer 3D Targeting is imaging software designed to support preoperative planning for shoulder arthroplasty. It uses two-dimensional images, such as an MRI of CT scan, to create a 3D interactive model and provide a surgical plan in advance of the Catalyst procedure.

For more information about Catalyst and its Archer suite of shoulder systems, visit booth #3452 at AAOS or www.CatalystOrtho.com.

About Catalyst OrthoScience Inc.
Catalyst OrthoScience is disrupting the usual approaches to shoulder replacement surgery.
Founded in 2014 by orthopedic surgeon Steven Goldberg, M.D., the company’s goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients. The company has a growing portfolio of patents and pending patents on its distinctive surgical offerings. Headquartered in Naples, Fla., Catalyst products are available across the U.S. For more information, visit www.CatalystOrtho.com/.

Share

Related posts

November 1, 2022

Catalyst Ranked One of the Top Ten Startup Companies in 2022


Read more
September 26, 2022

Hurricane Ian Update


Read more
April 12, 2022

Press Release: Catalyst OrthoScience Announces David Sharp as Vice President of Global Marketing


Read more

® indicates U.S. trademark registration. All trademarks and/or images are the property of their respective owners or holders. © 2020 Catalyst OrthoScience Inc.
All rights reserved.

    Nice to meet you. We use cookies to ensure that we give you the best experience on our website.

    Sounds Good